Innovative approach could spare patients unnecessary toxicity, lead to development of new therapies
Together with collaborators, we identified new biological markers that may predict which ovarian cancer patients won’t respond to chemotherapy. The paper describing this work, Chowdhury et al, was published online August 3 in Cell.
Please see below posts for details:
Fred Hutchinson Cancer Center News
University of Arkansas for Medical Sciences News
NIH Office of Cancer Clinical Proteomics Research News